# Jonathan Strosberg

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jonathan-strosberg/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,892 |
| Field | Neuroendocrine Tumor Research Advances |
| h-index | 70 |
| i10-index | 196 |
| Last Known Institution | Moffitt Cancer Center |
| OpenAlex ID | https://openalex.org/A5068503288 |
| ORCID iD | 0000-0001-8405-218X |
| Works | 430 |

## Researcher papers

Showing 12 of 16.

- [Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors](https://scholariq.org/papers/phase-3-trial-of-sup-177-sup-lu-dotatate-for-midgut-neuroendocrine-tumors/)
- [Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study](https://scholariq.org/papers/everolimus-for-the-treatment-of-advanced-non-functional-neuroendocrine-tumours/)
- [First‐line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas](https://scholariq.org/papers/first-line-chemotherapy-with-capecitabine-and-temozolomide-in-patients-with/)
- [Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/neuroendocrine-and-adrenal-tumors-version-2-2021-nccn-clinical-practice/)
- [Gastroenteropancreatic Neuroendocrine Tumors](https://scholariq.org/papers/gastroenteropancreatic-neuroendocrine-tumors/)
- [Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors](https://scholariq.org/papers/consensus-guidelines-for-the-management-and-treatment-of-neuroendocrine-tumors/)
- [Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With <sup>177</sup>Lu-Dotatate in the Phase III NETTER-1 Trial](https://scholariq.org/papers/health-related-quality-of-life-in-patients-with-progressive-midgut/)
- [NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018](https://scholariq.org/papers/nccn-guidelines-insights-neuroendocrine-and-adrenal-tumors-version-2-2018/)
- [The Surgical Management of Small Bowel Neuroendocrine Tumors](https://scholariq.org/papers/the-surgical-management-of-small-bowel-neuroendocrine-tumors/)
- [The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors](https://scholariq.org/papers/the-north-american-neuroendocrine-tumor-society-consensus-guidelines-for/)
- [Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors](https://scholariq.org/papers/appropriate-use-criteria-for-somatostatin-receptor-pet-imaging-in-neuroendocrine/)
- [The NANETS Consensus Guidelines for the Diagnosis and Management of Poorly Differentiated (High-Grade) Extrapulmonary Neuroendocrine Carcinomas](https://scholariq.org/papers/the-nanets-consensus-guidelines-for-the-diagnosis-and-management-of-poorly/)

## Researcher topics

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Gastrointestinal Tumor Research and Treatment](https://scholariq.org/topics/gastrointestinal-tumor-research-and-treatment/)

## Researcher university

- [Moffitt Cancer Center](https://scholariq.org/institutions/moffitt-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.